Variables | HRs | 95% Confidence interval | p-value |
---|---|---|---|
Men | |||
 Age (years) | 1.04 | 1.03–1.05 | < 0.001 |
 eGFR (ml/min/1.73 m2) | 0.90 | 0.89–0.91 | < 0.001 |
 FPG (mmol/l) | 1.10 | 1.05–1.16 | < 0.001 |
 DBP (mmHg) | 1.02 | 1.01–1.03 | < 0.001 |
 TC (mmol/l) | 0.89 | 0.83–0.96 | 0.0025 |
 Waist circumference (cm) | 0.98 | 0.97–0.99 | 0.016 |
 Hip circumference (cm) | 1.02 | 1.00–1.03 | 0.075 |
 Heart rate (beats/min) | 0.99 | 0.99–1.00 | 0.093 |
 Education | |||
  Level 1 (illiterate) | Reference |  |  |
  Level 2 (< 9 years) | 1.18 | 0.83–1.67 | 0.34 |
  Level 3 (9–12 years) | 1.24 | 0.87–1.78 | 0.23 |
  Level 4 (> 12 years) | 1.56 | 1.06–2.28 | 0.021 |
 Marital status | |||
  Married | Reference |  |  |
  Single | 1.06 | 0.77–1.47 | 0.70 |
  Divorced/widowed | 2.04 | 1.09–3.84 | 0.025 |
 FH–CVD in female relatives | |||
  No | Reference |  |  |
  Yes | 1.25 | 0.97–1.62 | 0.080 |
 PAL | |||
  Inactivea | Reference |  |  |
  Active | 1.21 | 1.03–1.42 | 0.016 |
 Smoking | |||
  Never | Reference |  |  |
  Past | 1.06 | 0.87–1.30 | 0.51 |
  Current | 1.24 | 1.03–1.48 | 0.017 |
 Use of blood glucose lowering drugs | |||
  No | Reference |  |  |
  Yes | 1.59 | 1.08–2.35 | 0.017 |
 Use of aspirin | |||
  No | Reference |  |  |
  Yes | 0.84 | 0.67–1.04 | 0.116 |
Women | |||
 Age (years) | 1.02 | 1.02–1.03 | < 0.001 |
 eGFR (mL/min/10.73 m2) | 0.91 | 0.91–0.92 | < 0.001 |
 FPG (mmol/L) | 1.05 | 1.02–1.08 | < 0.001 |
 Heart rate (beats/min) | 0.99 | 0.98–0.99 | < 0.001 |
 Waist circumference (cm) | 0.99 | 0.98–0.99 | 0.002 |
 SBP (mmHg) | 1.01 | 1.00–1.01 | 0.028 |
 Wrist circumference (cm) | 1.05 | 1.00–1.01 | 0.119 |
 FHD in first-degree relatives | |||
  No | Reference |  |  |
  Yes | 0.90 | 0.79–1.01 | 0.08 |
 Prevalence CVD | |||
  No | Reference |  |  |
  Yes | 1.35 | 0.99–1.82 | 0.048 |